Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asha Tipirneni

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|March 3, 2026
Neoadjuvant Systemic Therapy in Kidney and Bladder Cancer: Current Evidence and Emerging ParadigmsRana R McKay, Asha Tipirneni, Rick Bangs, et al.
JAMA Network Open|August 3, 2023
Extended Follow-Up of Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-Risk Resected MelanomaRachel S Goodman, Aleigha Lawless, Rachel Woodford, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|March 3, 2026
Neoadjuvant Systemic Therapy in Kidney and Bladder Cancer: Current Evidence and Emerging ParadigmsRana R McKay, Asha Tipirneni, Rick Bangs, et al.
JAMA Network Open|August 3, 2023
Extended Follow-Up of Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-Risk Resected MelanomaRachel S Goodman, Aleigha Lawless, Rachel Woodford, et al.
Pageof 1